Research shows IL‐6 is crucial in neuro‐immune crosstalk in pancreatic cancer—tumor and surrounding cells secrete IL‐6, which promotes tumor survival, drug resistance, and systemic symptoms like muscle wasting (cachexia), depression, and fatigue. Here, IL6 is linked to familial pancreatic carcinoma.